A number of viruses encode proteins that enhance virulence by modulation of host immune responses. Illustrative examples include the influenza A NS1 protein, which interferes with activation of cellular innate immune responses to viral infection, and translation products of the adenovirus E3 transcriptional unit, which serve to prevent cytotoxic T-cell recognition of virally infected cells and block immunologically activated signaling pathways that lead to infected-cell death.
In this way, immunomodulatory viral virulence determinants resemble classic bacterial virulence factors such as various types of secreted toxins.
The immune response to viral infection involves complex interactions among leukocytes, nonhematopoietic cells, signaling proteins, soluble proinflammatory mediators, antigen-presenting molecules, and antibodies. These cells and molecules collaborate in a highly regulated fashion to limit viral replication and dissemination through recognition of broadly conserved molecular signatures, followed by virus-specific adaptive responses that further control infection and establish antigen-selective immunologic memory.
The innate antiviral response is a local, transient, antigen-independent perimeter defense strategically focused at the site of virus incursion into an organ or tissue. Mediated by ancient families of membrane-associated and cytosolic molecules known as pattern recognition receptors PRRs , the innate immune system detects pathogen-associated molecular patterns PAMPs , which are fundamental structural components of microbial products including nucleic acids, carbohydrates, and lipids.
The adaptive immune response confers systemic and enduring pathogen-selective immunity through expansion and functional differentiation of viral antigen-specific T and B lymphocytes. Having both regulatory and effector roles, T lymphocytes are centrally positioned in the scheme of adaptive immunity.
For certain persistent viral infections, such as those caused by HIV and HSV, Treg cells might exacerbate disease through suppression of CTLs or, paradoxically, ameliorate illness by attenuating immune-mediated cell and tissue injury. Although Tfh cell functions are not unique to antiviral responses, chronic viral infections including HBV and HIV appear to stimulate proliferation of these cells. The primacy of cell-mediated immune responses in combating viral infections is revealed by the extreme vulnerability of individuals to chronic and life-threatening viral diseases when cellular immunity is dysfunctional.
Similarly, iatrogenic cellular immunodeficiency associated with hematopoietic stem cell and solid-organ transplantation or antineoplastic treatment regimens predisposes to severe, potentially fatal infections with herpesviruses and respiratory viral pathogens such as adenovirus, PIV, and RSV, all of which normally produce self-limited illness in immunocompetent hosts.
Prevention and management of serious viral respiratory infections are significant challenges in myelosuppression units because of the communicability of respiratory viruses and paucity of effective drugs to combat these ubiquitous agents. Individuals with significantly impaired cell-mediated immunity are also at increased risk for enhanced viral replication and systemic disease following immunization with live, attenuated viral vaccines e.
Hence, live viral vaccines are generally contraindicated for immunocompromised persons see Chapter In contrast to cell-mediated immune mechanisms, humoral responses are usually not a determinative factor in the resolution of primary viral infections. One notable exception is a syndrome of chronic enteroviral meningitis in the setting of agammaglobulinemia. Nevertheless, most human viruses, excluding insect-transmitted agents, enter their hosts by transgression of a mucosal barrier, frequently undergoing primary replication in mucosal epithelium or adjacent lymphoid tissues.
Neutralizing IgA exuded onto mucosal epithelial surfaces may protect against primary infection at this portal of viral entry. A classic example is gut mucosal immunity induced by orally administered Sabin poliovirus vaccine containing live-attenuated virus. Secretory IgA against poliovirus blocks infection at the site of primary replication and consequently interrupts the chain of viral transmission, although fully virulent revertant viruses arise at regular frequency in vaccine recipients, who may develop disease and also transmit revertant strains to nonimmune individuals.
Protection against viral infection by serum immunoglobulins is often correlated with antibody-mediated neutralization of viral infectivity in cultured cells. Antibodies interrupt the viral life cycle at early steps, which may include cross-linking virion particles into noninfectious aggregates, steric hindrance of receptor engagement, and interference with viral disassembly.
For example, exclusively in vivo functions of the humoral antiviral response include Fc-mediated virion phagocytosis , and antibody-dependent cell-mediated cytotoxicity ADCC. ADCC responses require effectors from both the innate and adaptive systems, NK cells and antibodies, respectively.
National Center for Biotechnology Information , U. Published online Oct James D. Chappell and Terence S. Guest Editor s : John E. Guest Editor s : Martin J. Blaser, MD Muriel G. Article notes Copyright and License information Disclaimer. Keywords: antiviral, apoptosis, cancer, innate immunity, pathogenesis, receptor, tropism, vaccine, virulence, virus.
All rights reserved. Elsevier hereby grants permission to make all its COVIDrelated research that is available on the COVID resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source.
History Viruses exact an enormous toll on the human population and are the single most important cause of infectious disease morbidity and mortality worldwide. Virus Structure and Classification The first classification of viruses as a group distinct from other microorganisms was based on the capacity to pass through filters of a small pore size filterable agents.
Open in a separate window. Data from Condit RC. Principles of virology. Fields Virology. Philadelphia: Lippincott-Raven Press; Structural studies of poliovirus. Virus—Cell Interactions Viruses require an intact cell to replicate and can direct the synthesis of hundreds to thousands of progeny viruses during a single cycle of infection. Attachment The interaction between a virus and its host cell begins with attachment of the virus particle to specific receptors on the cell surface.
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Penetration and Disassembly Once attachment has occurred, the virus must penetrate the cell membrane, and the capsid must undergo a series of disassembly steps uncoating that prepare the virus for the next phases in viral replication.
Mechanisms of viral entry into cells. Genome Replication Once a virus has entered a target cell, it must replicate its genome and proteins. Cell Killing Viral infection can compromise numerous cellular processes, such as nucleic acid and protein synthesis, maintenance of cytoskeletal architecture, and preservation of membrane integrity.
Reovirus-induced apoptosis in the murine central nervous system. PLoS Pathog. Virus—Host Interaction One of the most formidable challenges in virology is to apply knowledge gained from studies of virus—cell interactions in tissue culture systems to an understanding of how viruses interact with host organisms to cause disease. Entry The first step in the process of virus—host interaction is the exposure of a susceptible host to viable virus under conditions that promote infection Fig.
Entry and spread of viruses in human hosts. Entry, dissemination, shedding, and transmission of viruses. In: Nathanson N, ed. Viral Pathogenesis. Philadelphia: Lippincott-Raven; Spread Once a virus has entered the host, it can replicate locally or spread from the site of entry to distant organs to produce systemic disease see Fig. Pathogenesis of mousepox virus infection. Successive waves of viremia are shown to seed the spleen and liver and then the skin. From Fenner F. Mousepox [infectious ectromelia of mice]: a review.
J Immunol. Tropism The capability of a virus to infect a distinct group of cells in the host is referred to as tropism. Persistent Infections Many viruses are capable of establishing persistent infections, of which two types are recognized: chronic and latent.
Viruses and Cancer Several viruses produce disease by promoting malignant transformation of host cells. Viral Virulence Determinants Viral surface proteins involved in attachment and entry influence the virulence of diverse groups of viruses. Host Responses to Infection The immune response to viral infection involves complex interactions among leukocytes, nonhematopoietic cells, signaling proteins, soluble proinflammatory mediators, antigen-presenting molecules, and antibodies.
Key References The complete reference list is available online at Expert Consult. Clonal integration of a polyomavirus in human Merkel cell carcinoma.
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. Update: influenza activity—United States and worldwide, May September 22, Human infection with a novel avian-origin influenza A H7N9 virus.
Near-atomic resolution using electron cryomicroscopy and single-particle reconstruction. Electron cryotomography of measles virus reveals how matrix protein coats the ribonucleocapsid within intact virions. EMBO J. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid.
Structure of an HIV gp envelope glycoprotein in complex with the CD4 receptor and a neutralizing antibody. Three dimensional structure of poliovirus at 2. Haywood AM. Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol. PLoS Path. Spear PG. Viral interactions with receptors in cell junctions and effects on junctional stability.
Dev Cell. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. Atomic structure of the ectodomain from HIV-1 gp Virus entry by endocytosis.
Annu Rev Biochem. Structure of influenza haemagglutinin at the pH of membrane fusion. Three-dimensional visualization of mRNA release from actively transcribing rotavirus particles. Nat Struct Biol. The human papilloma virus E7 oncoprotein is able to bind to the retinoblastoma gene product. Host immune system gene targeting by a viral miRNA. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.
J Gen Virol. Cell Host Microbe. A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication. Adv Virus Res. Wileman T. Aggresomes and pericentriolar sites of virus assembly: cellular defense or viral design? Annu Rev Microbiol. Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell.
Cell Microbiol. Viruses and apoptosis. Everett H, McFadden G. Apoptosis: an innate immune response to virus infection. Trends Microbiol. Kiser JJ, Flexner C. Direct-acting antiviral agents for hepatitis C virus infection. Annu Rev Pharmacol Toxicol. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Antigenemia, RNAemia, and innate immunity in children with acute rotavirus diarrhea.
Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients. J Infect Dis. Directional release of reovirus from the apical surface of polarized endothelial cells. Herpesviruses use bidirectional fast-axonal transport to spread in sensory neurons. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.
McKnight S, Tijan R. Transcriptional selectivity of viral genes in mammalian cells. Regulation of inducible and tissue-specific gene expression. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Pathogen recognition by innate receptors. J Infect Chemother. Pang IK, Iwasaki A. Control of antiviral immunity by pattern recognition and the microbiome.
Immunol Rev. Interferon-inducible antiviral effectors. Nat Rev Immunol. Helper T cell diversity and plasticity.
Curr Opin Immunol. Regulatory T cells in virus infections. J Clin Invest. Slifka MK, Ahmed R. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Duration of humoral immunity to common viral and vaccine antigens. Curr Top Microbiol Immunol. Corti D, Lanzavecchia A. Broadly neutralizing antiviral antibodies. Annu Rev Immunol. References 1. Reed W. Recent researches concerning the etiology, propagation and prevention of yellow fever by the United States Army Commission.
J Hyg Lond ; 2 — A new arenavirus in a cluster of fatal transplant-associated diseases. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. Identification and characterization of a new orthoreovirus from patients with acute respiratory infections. PLoS One. Investigation of a potential zoonotic transmission of orthoreovirus associated with acute influenza-like illness in an adult patient.
Delbruck M. The growth of bacteriophage and lysis of the host. J Gen Physiol. Luria SE. Bacteriophage: an essay on virus reproduction. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med. Hershey AD, Chase M. Independent functions of viral protein and nucleic acid in the growth of bacteriophage.
Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Salk JE. Studies in human subjects on active immunization against poliomyelitis, I. A preliminary report of experiments in progress. History of Sabin attenuated poliovirus oral live vaccine strains.
J Biol Stand. Interaction of the poliovirus receptor with poliovirus. Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes.
Three-dimensional structure of rubella virus factories. Structural requirements for the assembly of Norwalk virus-like particles. Production of human papillomavirus type 16 virus-like particles in transgenic plants.
Guo P, Lee TJ. Mol Microbiol. Ahmed M, Lyles DS. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.
VSV strains with defects in their ability to shut down innate immunity are potent systemic anti-cancer agents. Cancer Cell. Three-dimensional visualization of the rotavirus hemagglutinin structure. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. Delineation of a region of the human immunodeficiency virus type 1 gp glycoprotein critical for interaction with the CD4 receptor. Structure of a human common cold virus and functional relationship to other picornaviruses.
The three dimensional structure of foot-and-mouth disease virus at 2. Virus receptors: Binding, adhesion strengthening, and changes in viral structure. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. Binding of herpes simplex virus to cellular heparan sulphate; an initial step in the adsorption process. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.
J Cell Biol. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor.
A cell surface protein with herpesvirus entry activity HveB confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Identification of a major co-receptor for primary isolates of HIV The GM2 glycan serves as a functional co-receptor for serotype 1 reovirus.
Junction adhesion molecule is a receptor for reovirus. Bats, in particular, are reservoirs for viruses. If these bat viruses mutate so they become capable of infecting humans, however, there will be new diseases, Maquat says. The hope is that we will be ready and able to develop vaccines against these new viruses with the new pipelines that have been put in place for COVID This story was originally published on April 28, , and updated on December 14, Please consider downloading the latest version of Internet Explorer to experience this site as intended.
December 14, A coronavirus uses a protein on its membrane—shown here in red in a molecular model—to bind to a receptor—shown in blue—on a human cell to enter the cell. Once inside, the virus uses the cells' machinery to make more copies of itself. People who are already in a long-term, mutually monogamous relationship are not likely to get a new HPV infection. There are HPV tests that can screen for cervical cancer. Healthcare providers only use these tests for screening women aged 30 years and older.
HPV tests are not recommended to screen men, adolescents, or women under the age of 30 years. Most people with HPV do not know they have the infection. They never develop symptoms or health problems from it.
Some people find out they have HPV when they get genital warts. Women may find out they have HPV when they get an abnormal Pap test result during cervical cancer screening. In that same year, there were 13 million new infections. Cervical cancer: Every year, nearly 12, women living in the U. More than 4, women die from cervical cancer—even with screening and treatment.
There are other conditions and cancers caused by HPV that occur in people living in the United States. Every year, about 19, women and 12, men experience cancers caused by HPV. This could be less than the actual number of people who get genital warts. Pregnant people with HPV can get genital warts or develop abnormal cell changes on the cervix. Routine cervical cancer screening can help find abnormal cell changes. Abstract Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder drug.
Publication types Systematic Review.
0コメント